K. M. Miller, R. W. Beck, R. M. Bergenstal, R. S. Goland, M. J. Haller et al., Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1C Levels in T1D Exchange Clinic Registry Participants. Diabetes Care, vol.36, pp.2009-2023, 2013.

B. Guerci, P. Benhamou, D. Durain, A. Bahloul, V. Jeanbat et al., Pratique de l'autosurveillance glycémique en France : données d'une enquête nationale, vol.29, pp.229-240

G. Reach, Toutes les questions que vous vous êtes toujours posées sur le fonctionnement des capteurs de glucose, Médecine des maladies métaboliques-Novembre, vol.10, pp.615-623, 2016.

J. R. Petrie, A. L. Peters, R. M. Bergenstal, R. W. Holl, G. A. Fleming et al., Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group, Diabetes Care, vol.40, issue.12, pp.1614-1621, 2017.

M. Lind, W. Polonsky, B. Hirsch, T. Heise, J. Bolinder et al., Continuous Glucose Monitoring vs Convetional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiples Daily Insulin Injections The GOLD Randomized Clinicla Trial, JAMA, vol.317, issue.4, pp.379-387, 2017.

P. Oskarsson, R. Antuna, P. Geelhoed-duijvestijn, J. Kr?ger, R. Weitgasser et al., mpact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial, Diabetologia, vol.61, issue.3, pp.539-550, 2018.

S. A. Little, L. Leelarathna, E. Walkinshaw, H. K. Tan, O. Chapple et al., Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS), vol.37, pp.2114-2136, 2014.

N. Hermanns, L. Heinemann, G. Freckmann, D. Waldenmaier, and D. Ehrmann, Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study, J Diabetes Sci Technol, vol.13, issue.4, pp.636-644, 2019.

M. A. O'connell, S. Donath, O. Neal, D. N. Colman, P. G. Ambler et al., Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial, Diabetologia, vol.52, issue.7, pp.1250-1257, 2009.

T. -battelino, I. Conget, B. Olsen, I. Schütz-fuhrmann, E. Hommel et al., The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial, Diabetologia, vol.55, issue.12, pp.3155-3162, 2012.

S. -charleer, C. Mathieu, F. Nobels, D. Block, C. Radermecker et al., Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study, J Clin Endocrinol Metab, vol.103, issue.3, pp.1224-1232, 2018.

T. C. Dunn, Y. Xu, G. Hayter, and R. A. Ajjan, Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests, Diabetes Res Clin Pract, vol.137, pp.37-46, 2018.

A. F. -Ólafsdóttir, S. Attvall, U. Sandgren, S. Dahlqvist, A. Pivodic et al., A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1 Diabetes, Diabetes Technol Ther, vol.19, issue.3, pp.164-172, 2017.

L. -leelarathna and E. G. Wilmot, Flash forward: a review of flash glucose monitoring, Diabet Med, vol.35, issue.4, pp.472-482, 2018.

Y. C. -kudva, A. J. Ahmann, R. M. Bergenstal, J. R. Gavin, D. F. Kruger et al., Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults, Journal of the Endocrine Society, vol.2, pp.1320-1337, 2018.

-. Platinium,

K. Nakamura and A. Balo, The Accuracy and Efficacy of the Dexcom G4 Platinum Continuous Glucose Monitoring System, J Diabetes Sci Technol, vol.9, issue.5, pp.1021-1027, 2015.

S. Borot, P. Y. Benhamou, C. Atlan, E. Bismuth, E. Bonnemaison et al., Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement, Diabetes Metab, vol.44, issue.1, pp.61-72, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01741145

M. Joubert and Y. Reznik, Personal continuous glucose monitoring (CGM) in diabetes management: Review of the literature and implementation for practical use, Diabetes Research and Clinical Practice, vol.96, issue.3, pp.294-305, 2012.

H. Hanaire, C. Atlan, P. Y. Benhamou, E. Bismuth, E. Bonnemaison et al., Éducation à l'utilisation pratique et à l'interprétation de la Mesure Continue du Glucose : position d'experts françaisPractical implementation, education and interpretation guidelines for Continuous Glucose Monitoring: a French position statement, Médecine des Maladies Métaboliques, vol.11, issue.4, pp.1-37, 2017.

R. M. Bergenstal, R. W. Beck, K. L. Close, G. Grunberger, D. B. Sacks et al., Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring, Diabetes Care, vol.41, issue.11, pp.2275-2280, 2018.

T. Battelino, T. Danne, R. M. Bergenstal, S. A. Amiel, R. Beck et al., Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range, Diabetes Care, vol.42, issue.8, pp.1593-1603, 2019.

, Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, Hypoglycaemia Study Group, vol.40, pp.155-157, 2017.

A. E. -gold, K. M. Macleod, and B. M. Frier, Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care, vol.17, pp.697-703, 1994.

W. L. Clarke, D. J. Cox, L. A. Gonder-frederick, D. Julian, D. Schlundt et al., Reduced Awareness of Hypoglycemia in Adults With IDDM: A prospective study of hypoglycemic frequency and associated symptoms, Diabetes Care, vol.18, issue.4, pp.517-522, 1995.

L. -gonder-frederick, K. M. Schmidt, K. A. Vadja, M. L. Greear, H. Singh et al., Psychometric Properties of the Hypoglycemia Fear Survey-II for Adults With Type 1 Diabetes. Diabetes Care, vol.34, pp.801-806, 2011.

C. Bradley, C. Todd, T. Gorton, E. Symonds, A. Martin et al., The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL, Qual Life Res, vol.8, issue.1-2, pp.79-91, 1999.

Y. Saisho, Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes Int, J Environ Res Public Health, vol.15, issue.5, p.947, 2018.

E. -bosi, P. Choudhary, H. W. De-walk, S. Lablanche, J. Castaneda et al., Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial. The Lancet Diabetes and Endocrinology, vol.7, pp.462-472, 2019.

J. P. -riveline, P. Schaepelynck, L. Chaillous, R. E. Sola-gazagnes, A. Penfornis et al., Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care, vol.35, pp.965-71, 2012.

Z. -mian, K. L. Hermayer, and A. Jenkins, Continuous Glucose Monitoring: Review of an Innovation in Diabetes Management, Am J Med Sci, issue.19, pp.30267-30275, 2019.

M. Reddy, N. Jugnee, S. Anantharaja, and N. Oliver, Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study, Diabetes Technol Ther, vol.20, issue.11, pp.751-757, 2018.

F. 33-boscari, S. Galasso, A. Facchinetti, M. C. Marescotti, V. Vallone et al., FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions, Metabolism & Cardiovascular Diseases, vol.28, pp.180-186, 2018.

J. ?oupal, L. Petru?elková, and M. Fleka?, Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, 52 Weeks of Follow-Up: A COMISAIR Study, vol.18, pp.532-538, 2016.

S. Roze, J. Smith-palmer, S. De-portu, A. Delbaere, B. De-brouwer et al., Costeffectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands, Clinicoecon Outcomes Res, vol.11, pp.73-82, 2019.

W. 36-wan, M. R. Skandari, A. Minc, A. G. Nathan, A. Winn et al., Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial, Diabetes Care, vol.41, issue.6, pp.1227-1234, 2018.